by Life Sciences Nova Scotia | Jun 22, 2026 | News
Date: June 22, 2026 From: AbbVie NORTH CHICAGO, Ill. and SAN FRANCISCO and BOSTON AbbVie (NYSE: ABBV) and Apogee Therapeutics (NASDAQ: APGE) (“Apogee”) today announced they have entered into a definitive agreement under which AbbVie will acquire Apogee...
by Life Sciences Nova Scotia | Jun 8, 2026 | News
Date: June 8, 2026 Seven Life Sciences Nova Scotia member companies are heading to San Diego this June, joining the Atlantic Canada delegation at the BIO International Convention 2026 (June 22–25). Together, they represent the breadth and ambition of Nova...
by Life Sciences Nova Scotia | Mar 13, 2026 | News
From: Agilent Technologies Inc.Date: Mar.11, 2026 Agilent Technologies Inc. today announced the launch of Agilent Advanced Therapeutics, a unified Contract Development and Manufacturing Organization (CDMO) solution integrating the company’s expanding capabilities...
by Life Sciences Nova Scotia | Feb 20, 2026 | News
From: EntrevestorDate: Feb.18, 2026 ABK Biomedical late last year raised US$35 million (C$47.9 million) in a Series D financing round to support clinical trials, manufacturing expansion and development of a product to be used in treating liver cancer. The...
by Life Sciences Nova Scotia | Feb 5, 2026 | News
From: The Information and Communications Technology Council (ICTC)Date: Feb.5, 2026 The Information and Communications Technology Council (ICTC) recently announced 30 new partnerships with organizations across Canada (including LSNS) under their Work-Integrated...
by Life Sciences Nova Scotia | Jan 29, 2026 | News
From: EntrevestorDate: Jan.27, 2026 Halifax-based Stroke of Luck is focused on creating affordable, AI-powered hardware and software that offers home-based brain-training therapy for stroke patients. Founder Steve MacDougall himself suffered a stroke four years ago...
